Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from participants who have received capsules from a more recently ma ...

CervoMed (CRVO) provided an update on its neflamapimod development program in dementia with Lewy bodies, DLB, as part of an oral presentation ...

A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...

Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, ...

A once-a-day pill that could be the “holy grail” in the treatment of Alzheimer’s disease is a step closer to becoming a ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making ... Help to Track the Pathological Progression of Lewy's Body Disease July 31, 2024 — New research suggests ...

( MENAFN - Mid-East Info) DUBAI, United Arab Emirates; January 2025 - Mayo clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

Many people use the terms Alzheimer’s disease and dementia as if they mean the same thing, but they actually refer to ...